Alain van Mil
- Cancer Research top 2%
- MicroRNA in disease regulation 15
- Molecular Biology top 10%
- Pluripotent Stem Cells Research 9
- Congenital heart defects research 8
- RNA Interference and Gene Delivery 7
- CRISPR and Genetic Engineering 7
- Circular RNAs in diseases 7
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications 6
- Surgery top 10%
- Tissue Engineering and Regenerative Medicine 13
- Co-authors
- Joost P. G. SluijterPieter A. DoevendansCorina H.G. MetzMarie‐José GoumansJia LiuPatrick van VlietMarish I.F.J. OerlemansMark Mercola
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Alain van Mil
39 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 775
- Molecular Biology 1.1k
- Biomaterials 184
- Cardiology and Cardiovascular Medicine 242
- Surgery 300
Countries citing papers authored by Alain van Mil
This map shows the geographic impact of Alain van Mil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain van Mil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain van Mil more than expected).
Fields of papers citing papers by Alain van Mil
This network shows the impact of papers produced by Alain van Mil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain van Mil. The network helps show where Alain van Mil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alain van Mil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 24 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 23 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 5 | |
| 12 | 2016 | 23 | |
| 13 | 2014 | 326 | |
| 14 | 2013 | 24 | |
| 15 | 2012 | 169 | |
| 16 | 2012 | 114 | |
| 17 | 2012 | 34 | |
| 18 | 2010 | 105 | |
| 19 | 2009 | 25 | |
| 20 | 2009 | 13 |
About Alain van Mil
Alain van Mil is a scholar working on Cancer Research, Aging and Biomaterials, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Tissue Engineering and Regenerative Medicine (13 papers), Pluripotent Stem Cells Research (9 papers), Congenital heart defects research (8 papers), RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (7 papers), Circular RNAs in diseases (7 papers) and Electrospun Nanofibers in Biomedical Applications (6 papers). The work is most often cited by research in Cancer Research (775 citations), Molecular Biology (1.1k citations) and Biomaterials (184 citations). Alain van Mil has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Joost P. G. Sluijter, Pieter A. Doevendans, Corina H.G. Metz, Marie‐José Goumans, Pieter A. Doevendans, Jia Liu, Patrick van Vliet, Marish I.F.J. Oerlemans, Mark Mercola and Christine Wahlquist. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.